申请人:Myers Andrew G.
公开号:US20090054665A1
公开(公告)日:2009-02-26
Disclosed herein are analogs of Salinosporamide A, having the Formula I as follows:
Like Salinosporamide A, the compounds of the present invention will inhibit the proteasome, an intracellular enzyme complex that destroys proteins the cell no longer needs. Without the proteasome, proteins would build up and clog cellular machinery. Fast-growing cancer cells make especially heavy use of the proteasome, so thwarting its action is a compelling drug strategy.
本文披露了类似于盐链霉素A的类似物,其化学式为I,如下所示:与盐链霉素A一样,本发明的化合物将抑制蛋白酶体,一种细胞内酶复合物,用于分解细胞不再需要的蛋白质。没有蛋白酶体,蛋白质将积累并阻塞细胞机制。快速生长的癌细胞尤其大量利用蛋白酶体,因此阻碍其作用是一种引人注目的药物策略。